Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
click here now to get all the chilling details.
Lance Alstodt net worth and biography

Lance Alstodt Biography and Net Worth

Lance Alstodt has been appointed the Company’s President, Chief Executive Officer and Chairman of the Board as of Nov 16, 2020.  Mr. Alstodt brings over 25 years of experience in leading medical technology and lifesciences companies in operations, capital raising activities, strategy, and mergers and acquisitions.

Most recently, Mr. Alstodt was the Founder and CEO of MedVest Consulting Corporation (“MedVest”), an advisory and capital firm focused exclusively within the healthcare sector, focusing on growth and channel strategy, strategic planning, merger and acquisition support and investor activities.

Prior to MedVest, Mr. Alstodt was a career investment banker with over 25 years of experience in healthcare investment banking, including mergers and acquisitions. In 2011, Mr. Alstodt joined Leerink Partners as Managing Director to help lead its medical technology sector. Mr. Alstodt brings significant domain experience within the orthopedic and spine specific sectors. From 2008-2011, Mr. Alstodt was a Managing Director and Head of Medical Technology at Oppenheimer & Co. From 2000-2008, he was a Managing Director in the Healthcare Group and Global M&A Group at Bank of America Merrill Lynch (“BAML”). Prior to BAML, Mr. Alstodt spent seven years in the Global M&A Group at J.P. Morgan Chase, where he worked extensively on acquisitions, leveraged buyouts, private and public financings, exclusive sales and general advisory assignments.

Mr. Alstodt received a B.A. in Economics from the State University of New York at Albany, with a secondary concentration in Finance and Marketing.

What is Lance Alstodt's net worth?

The estimated net worth of Lance Alstodt is at least $562,030.21 as of January 20th, 2023. Mr. Alstodt owns 186,721 shares of BioRestorative Therapies stock worth more than $562,030 as of January 28th. This net worth evaluation does not reflect any other investments that Mr. Alstodt may own. Learn More about Lance Alstodt's net worth.

How do I contact Lance Alstodt?

The corporate mailing address for Mr. Alstodt and other BioRestorative Therapies executives is 40 MARCUS DRIVE, MELVILLE NY, 11747. BioRestorative Therapies can also be reached via phone at (631) 760-8100 and via email at [email protected] Learn More on Lance Alstodt's contact information.

Has Lance Alstodt been buying or selling shares of BioRestorative Therapies?

During the last ninety days, Lance Alstodt has bought $2,178.00 of BioRestorative Therapies stock. Most recently, on Friday, January 20th, Lance Alstodt bought 200 shares of BioRestorative Therapies stock. The stock was acquired at an average cost of $3.13 per share, with a total value of $626.00. Following the completion of the transaction, the chief executive officer now directly owns 186,721 shares of the company's stock, valued at $584,436.73. Learn More on Lance Alstodt's trading history.

Who are BioRestorative Therapies' active insiders?

BioRestorative Therapies' insider roster includes Lance Alstodt (CEO), and Francisco Silva (VP). Learn More on BioRestorative Therapies' active insiders.

Are insiders buying or selling shares of BioRestorative Therapies?

During the last year, BioRestorative Therapies insiders bought shares 43 times. They purchased a total of 201,494 shares worth more than $984,160.62. The most recent insider tranaction occured on January, 20th when CEO Lance Alstodt bought 200 shares worth more than $626.00. Insiders at BioRestorative Therapies own 17.6% of the company. Learn More about insider trades at BioRestorative Therapies.

Information on this page was last updated on 1/20/2023.

Lance Alstodt Insider Trading History at BioRestorative Therapies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/20/2023Buy200$3.13$626.00186,721View SEC Filing Icon  
1/18/2023Buy400$3.11$1,244.00186,521View SEC Filing Icon  
1/9/2023Buy100$3.08$308.00186,121View SEC Filing Icon  
12/23/2022Buy300$3.01$903.00186,021View SEC Filing Icon  
12/7/2022Buy1,800$2.99$5,382.00185,721View SEC Filing Icon  
11/18/2022Buy1,000$2.88$2,880.00183,921View SEC Filing Icon  
9/22/2022Buy200$2.92$584.00182,921View SEC Filing Icon  
7/12/2022Buy700$2.95$2,065.00182,721View SEC Filing Icon  
6/30/2022Buy1,100$3.10$3,410.00182,021View SEC Filing Icon  
6/15/2022Buy700$3.68$2,576.00180,321View SEC Filing Icon  
6/13/2022Buy200$3.95$790.00179,121View SEC Filing Icon  
6/8/2022Buy100$4.28$428.00178,921View SEC Filing Icon  
6/1/2022Buy200$4.60$920.00178,821View SEC Filing Icon  
5/26/2022Buy2,700$3.52$9,504.00178,621View SEC Filing Icon  
5/2/2022Buy400$3.95$1,580.00175,921View SEC Filing Icon  
1/24/2022Buy1,470$3.40$4,998.00View SEC Filing Icon  
1/5/2022Buy2,000$3.85$7,700.00View SEC Filing Icon  
12/1/2021Buy799$5.50$4,394.50View SEC Filing Icon  
11/22/2021Buy396$6.31$2,498.76View SEC Filing Icon  
11/16/2021Buy4,500$6.71$30,195.00View SEC Filing Icon  
8/27/2019Buy10,000$0.28$2,800.00View SEC Filing Icon  
8/21/2019Buy10,000$0.25$2,500.00View SEC Filing Icon  
See Full Table

Lance Alstodt Buying and Selling Activity at BioRestorative Therapies

This chart shows Lance Alstodt's buying and selling at BioRestorative Therapies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioRestorative Therapies Company Overview

BioRestorative Therapies logo
Biorestorative Therapies Inc. provides stem cell collections, storage, and treatment services. It intends to develop a laboratory, performing cellular characterization and culturing, therapeutic outcomes analysis, stem cell-related IP and stem cell collection and storage services. The firm is developing the following scientific programs: brtxDISC, which offers a non-surgical treatment for bulging and herniated discs and addresses the gap between non-invasive and invasive back procedures and ThermoStem, which involves the use of a cell-based, brown adipose tissue construct, treatment for metabolic disease, such as type 2 diabetes, obesity, hypertension, and other metabolic disorders, as well as cardiac deficiencies. Its products are sold under the BRTX-100, ThermoStem and Stem Pearls trademarks. The company was founded on June 13, 1997 and is headquartered in Melville, NY.
Read More

Today's Range

Now: $3.01
Low: $2.95
High: $3.07

50 Day Range

MA: $2.98
Low: $2.58
High: $3.68

2 Week Range

Now: $3.01
Low: $2.46
High: $5.97


3,841 shs

Average Volume

7,330 shs

Market Capitalization

$10.99 million

P/E Ratio


Dividend Yield



Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
click here now to get all the chilling details.